Primes clinical team shares the latest Check out the most recent indications for these popular medications to treat a growing range of conditions Carole Kerzic, RPh, is a principal drug information pharmacist at Prime Therapeutics and executive editor of several pipeline publications
Mounjaro is NOT included in the 2026 Medicare GLP-1 Bridge ($50/month, July 1, 2026 Dec 31, 2027), which covers weight-loss-approved products only
Nano Biomed Eng 16(3):345356
Medical oversight and symptom management guidance are included in your subscription
As of 2024, retatrutide is still in Phase 3 clinical trials
Those results often continue to improve for weeks, months, or even years